ClinicalTrials.gg
CompletedNCT02443051Updated May 16, 2017

Treatment of Social Anxiety in Youth

An interventional study of Attention Bias Modification in Social Anxiety Disorder, sponsored by Virginia Polytechnic Institute and State University. Completed at 1 site in United States. Open to participants aged 11 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-05-16.

Sponsored by Virginia Polytechnic Institute and State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
11 Years to 16 Years
Sex
All
01

Study summary

This research is designed to determine the effectiveness of attention bias modification for socially anxious children and adolescents. Over the course of 3 years, 50 youth will be enrolled in the trial.

Read the detailed description

The primary objective of this study is to develop an Attention Training (AT) protocol for adolescents with social anxiety disorder (SAD). Attentional biases to threat have been shown to be associated with the development and maintenance of anxiety disorders, in both adults and youth. Given these relations, AT paradigms have been developed to modify these attentional biases. Such paradigms have been shown to be promising in the treatment of adult anxiety. However, to date, only two small studies have examined the use of AT with children, and no ATT protocol has been developed specifically for use with children or adolescents. This is important, given the complications and possible ineffectiveness of applying adult-designed therapies to youth. Given this gap in the literature, the primary aims of the current study are intended to develop a treatment program to address attentional biases and anxiety in adolescents with SAD, to collect preliminary data regarding the program's short-term efficacy and feasibility, and to explore attention biases as a mediator and moderator of initial treatment outcomes. It is hypothesized that the AT protocol developed in the current project, compared to a placebo control comparator condition, will result in reductions in social anxiety among a sample of adolescents with SAD. Further, the AT protocol is expected to reduce attentional biases to threat among those adolescents who possess such biases prior to treatment (not all adolescents are expected to show this bias yet AT has been shown to be potentially effective with these youth; the presence/absence of attention bias will be explored as a moderator of change). The proposed study will be a pivotal step towards assessing the feasibility of an adolescent-focused AT procedure for the treatment of SAD. Results will contribute to an emerging body of research exploring the ameliorating effects of experimental paradigms that target information processing biases in anxious youth. Given emerging evidence regarding the use of AT in adult populations, findings from this study may have implications for improving the current prevention and treatment options available for anxious adolescents.

02

Conditions studied

  • Social Anxiety Disorder

Browse trials for

03

In context

Phobia, Social

353 studies on the registry are indexed under Phobia, Social; 61 are open to participants now.

This study's enrollment of 58 is below the median of 77 across 325 interventional studies indexed under Phobia, Social.

Browse Phobia, Social studies →

Lead sponsor

Virginia Polytechnic Institute and State University is the lead sponsor of 126 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Social Anxiety Disorder;
  • English Speaking

Exclusion criteria

Exclusion Criteria:

  • Suicide Intent,
  • Psychosis,
  • Autism Spectrum Disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
58 participants (actual)

Study arms

  • Experimental
    Attention Bias Modification

    Training in bias modification for 80% of experimental trials

    Behavioral: Attention Bias Modification

  • Active comparator
    Control

    Bias modification for 50% of trials

    Behavioral: Attention Bias Modification

Interventions

  • BehavioralAttention Bias Modification

    Computer delivered modification in 80% of trials

06

What researchers measure

Primary outcomes

  1. Clinician Severity Rating

    Immediately following treatment

    Time frame: Post-treatment

07

Study locations

1 site
  • Child Study Center
    Blacksburg, Virginia 24060, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02443051
Responsible party
Thomas H. Ollendick (Professor - Principal Investigator, Virginia Polytechnic Institute and State University) — Principal investigator
First posted
May 13, 2015
Start date
May 2013
Primary completion
May 2016
Completion
Dec 2016
Last update
May 16, 2017

Study contacts

Thomas H. Ollendick, Ph.D.
principal investigator · Virginia Polytechnic Institute and State University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion